Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips.

Andersson M, Scheidweiler KB, Sempio C, Barnes AJ, Huestis MA.

Anal Bioanal Chem. 2016 Sep;408(23):6461-71. doi: 10.1007/s00216-016-9765-8. Epub 2016 Jul 15.

PMID:
27422645
2.

Comparison of cannabinoids in hair with self-reported cannabis consumption in heavy, light and non-cannabis users.

Taylor M, Lees R, Henderson G, Lingford-Hughes A, Macleod J, Sullivan J, Hickman M.

Drug Alcohol Rev. 2017 Mar;36(2):220-226. doi: 10.1111/dar.12412. Epub 2016 Jun 14.

3.

Development and validation of an automated liquid-liquid extraction GC/MS method for the determination of THC, 11-OH-THC, and free THC-carboxylic acid (THC-COOH) from blood serum.

Purschke K, Heinl S, Lerch O, Erdmann F, Veit F.

Anal Bioanal Chem. 2016 Jun;408(16):4379-88. doi: 10.1007/s00216-016-9537-5. Epub 2016 Apr 26.

4.

Further Evidence That Cannabis Moderates Familial Correlation of Psychosis-Related Experiences.

van Winkel R; GROUP Investigators..

PLoS One. 2015 Sep 18;10(9):e0137625. doi: 10.1371/journal.pone.0137625. eCollection 2015.

5.

Risks associated with the non-medicinal use of cannabis.

Hoch E, Bonnetn U, Thomasius R, Ganzer F, Havemann-Reinecke U, Preuss UW.

Dtsch Arztebl Int. 2015 Apr 17;112(16):271-8. doi: 10.3238/arztebl.2015.0271. Review.

6.

Intellectual, neurocognitive, and academic achievement in abstinent adolescents with cannabis use disorder.

Hooper SR, Woolley D, De Bellis MD.

Psychopharmacology (Berl). 2014 Apr;231(8):1467-77. doi: 10.1007/s00213-014-3463-z. Epub 2014 Mar 12.

7.

Evidence that transition from health to psychotic disorder can be traced to semi-ubiquitous environmental effects operating against background genetic risk.

van Nierop M, Janssens M; Genetic Risk OUtcome of Psychosis Investigators., Bruggeman R, Cahn W, de Haan L, Kahn RS, Meijer CJ, Myin-Germeys I, van Os J, Wiersma D.

PLoS One. 2013 Nov 6;8(11):e76690. doi: 10.1371/journal.pone.0076690. eCollection 2013.

8.

Chemistry, metabolism, and toxicology of cannabis: clinical implications.

Sharma P, Murthy P, Bharath MM.

Iran J Psychiatry. 2012 Fall;7(4):149-56.

9.

Quantifying the clinical significance of cannabis withdrawal.

Allsop DJ, Copeland J, Norberg MM, Fu S, Molnar A, Lewis J, Budney AJ.

PLoS One. 2012;7(9):e44864. doi: 10.1371/journal.pone.0044864. Epub 2012 Sep 26.

10.

AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder.

van Winkel R, van Beveren NJ, Simons C; Genetic Risk and Outcome of Psychosis (GROUP) Investigators..

Neuropsychopharmacology. 2011 Nov;36(12):2529-37. doi: 10.1038/npp.2011.141. Epub 2011 Jul 20.

11.

Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH).

Holland MG, Schwope DM, Stoppacher R, Gillen SB, Huestis MA.

Forensic Sci Int. 2011 Oct 10;212(1-3):247-51. doi: 10.1016/j.forsciint.2011.06.028. Epub 2011 Jul 20.

12.

Just say "I don't": lack of concordance between teen report and biological measures of drug use.

Delaney-Black V, Chiodo LM, Hannigan JH, Greenwald MK, Janisse J, Patterson G, Huestis MA, Ager J, Sokol RJ.

Pediatrics. 2010 Nov;126(5):887-93. doi: 10.1542/peds.2009-3059. Epub 2010 Oct 25.

13.

Prenatal and postnatal cocaine exposure predict teen cocaine use.

Delaney-Black V, Chiodo LM, Hannigan JH, Greenwald MK, Janisse J, Patterson G, Huestis MA, Partridge RT, Ager J, Sokol RJ.

Neurotoxicol Teratol. 2011 Jan-Feb;33(1):110-9. doi: 10.1016/j.ntt.2010.06.011. Epub 2010 Jul 6.

14.

Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.

Milman G, Barnes AJ, Lowe RH, Huestis MA.

J Chromatogr A. 2010 Feb 26;1217(9):1513-21. doi: 10.1016/j.chroma.2009.12.053. Epub 2010 Jan 4.

15.

Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.

Lowe RH, Abraham TT, Darwin WD, Herning R, Cadet JL, Huestis MA.

Drug Alcohol Depend. 2009 Nov 1;105(1-2):24-32. doi: 10.1016/j.drugalcdep.2009.05.027. Epub 2009 Jul 23.

Supplemental Content

Support Center